India's COVID-19 vaccine export ban excludes Bangladesh: Minister
India's drug regulator Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Bangladesh Health | Biotechnology | COVID-19 | Emergency Medicine | India Health | Pharmaceuticals | Vaccines